202 related articles for article (PubMed ID: 16010955)
1. [Percutaneous radiologic thermocoagulation treatment of liver, kidney and lung tumours].
Kroft LJ; van der Linden E; Obermann WR
Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1448-53. PubMed ID: 16010955
[TBL] [Abstract][Full Text] [Related]
2. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results.
Fotiadis NI; Sabharwal T; Morales JP; Hodgson DJ; O'Brien TS; Adam A
Eur Urol; 2007 Sep; 52(3):777-84. PubMed ID: 17400364
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system.
Weisbrod AJ; Atwell TD; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
J Vasc Interv Radiol; 2007 Dec; 18(12):1528-32. PubMed ID: 18057287
[TBL] [Abstract][Full Text] [Related]
4. [Radiofrequency in cancerology].
de Baere T
Bull Cancer; 2005 Jan; 92(1):65-74. PubMed ID: 15689326
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous pulmonary metastasectomy and hepatic radiofrequency ablation to treat recurrent metastases from rectal cancer.
Julianov A; Karashmalakov A
Eur J Cancer Care (Engl); 2006 Sep; 15(4):369-70. PubMed ID: 16968319
[No Abstract] [Full Text] [Related]
8. [Radiofrequency tumor ablation: from the liver to the lung passing by the kidney].
Denys A; Doenz F; Qanadli SD; Chevallier P
Rev Med Suisse; 2005 Jul; 1(27):1774-8. PubMed ID: 16119290
[TBL] [Abstract][Full Text] [Related]
9. Dual-energy computed tomography to assess tumor response to hepatic radiofrequency ablation: potential diagnostic value of virtual noncontrast images and iodine maps.
Lee SH; Lee JM; Kim KW; Klotz E; Kim SH; Lee JY; Han JK; Choi BI
Invest Radiol; 2011 Feb; 46(2):77-84. PubMed ID: 20856125
[TBL] [Abstract][Full Text] [Related]
10. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors influencing the development of an iatrogenic pneumothorax for computed tomography-guided radiofrequency ablation of upper renal tumor.
Park BK; Kim CK
Acta Radiol; 2008 Dec; 49(10):1200-6. PubMed ID: 19031183
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.
Marshall FF
J Urol; 2005 Nov; 174(5):1782. PubMed ID: 16217284
[No Abstract] [Full Text] [Related]
15. Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies.
Clasen S; Krober SM; Kosan B; Aebert H; Fend F; Bomches A; Claussen CD; Pereira PL
Cancer; 2008 Dec; 113(11):3121-9. PubMed ID: 18973180
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496
[TBL] [Abstract][Full Text] [Related]
17. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
[TBL] [Abstract][Full Text] [Related]
18. How I do it: radiofrequency ablation and cryoablation of lung tumors.
Sharma A; Moore WH; Lanuti M; Shepard JA
J Thorac Imaging; 2011 May; 26(2):162-74. PubMed ID: 21508737
[TBL] [Abstract][Full Text] [Related]
19. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation of liver cancer.
Lencioni R; Crocetti L
Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
